Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 12
2000 4
2001 6
2003 1
2006 27
2008 1
2010 2
2011 1
2012 17
2014 3
2016 1
2017 1
2018 8
2019 289
2020 93208
2021 140576
2022 130926
2023 89652
2024 59045
2025 42543
2026 7762

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

500,999 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean covid-19 NOT pre print[pt] (506,351 results)?
Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19.
Majumder J, Minko T. Majumder J, et al. AAPS J. 2021 Jan 5;23(1):14. doi: 10.1208/s12248-020-00532-2. AAPS J. 2021. PMID: 33400058 Free PMC article. Review.
The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made a serious public health threat worldwide with millio …
The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory …
COVID-19 diagnosis -A review of current methods.
Yüce M, Filiztekin E, Özkaya KG. Yüce M, et al. Biosens Bioelectron. 2021 Jan 15;172:112752. doi: 10.1016/j.bios.2020.112752. Epub 2020 Oct 24. Biosens Bioelectron. 2021. PMID: 33126180 Free PMC article. Review.
SARS-CoV-2 (formerly, 2019-nCoV) infection was first reported in Wuhan (China) in December 2019, and then it has rapidly spread around the world, causing (~)14 million active cases with (~)582,000 deaths as of July 2020. The diagnosis tools avai …
SARS-CoV-2 (formerly, 2019-nCoV) infection was first reported in Wuhan (China) in December 2019, and then …
COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management.
Ochani R, Asad A, Yasmin F, Shaikh S, Khalid H, Batra S, Sohail MR, Mahmood SF, Ochani R, Hussham Arshad M, Kumar A, Surani S. Ochani R, et al. Infez Med. 2021 Mar 1;29(1):20-36. Infez Med. 2021. PMID: 33664170 Free article. Review.
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), the causative pathogen for the COVID-19, first emerged in Wuhan, China, in December 2019 and by March 2020, it was declared a pandemic. ... …
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), the causative p …
Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19).
Umakanthan S, Sahu P, Ranade AV, Bukelo MM, Rao JS, Abrahao-Machado LF, Dahal S, Kumar H, Kv D. Umakanthan S, et al. Postgrad Med J. 2020 Dec;96(1142):753-758. doi: 10.1136/postgradmedj-2020-138234. Epub 2020 Jun 20. Postgrad Med J. 2020. PMID: 32563999 Free PMC article. Review.
This article reviews the current state of knowledge concerning the origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Historically, it has caused two pandemics: severe acute respiratory syndrome and Middle East respiratory …
This article reviews the current state of knowledge concerning the origin, transmission, diagnosis and management of coronavirus dise …
Resolution of coronavirus disease 2019 (COVID-19).
Habas K, Nganwuchu C, Shahzad F, Gopalan R, Haque M, Rahman S, Majumder AA, Nasim T. Habas K, et al. Expert Rev Anti Infect Ther. 2020 Dec;18(12):1201-1211. doi: 10.1080/14787210.2020.1797487. Epub 2020 Aug 4. Expert Rev Anti Infect Ther. 2020. PMID: 32749914 Review.
INTRODUCTION: Coronavirus disease 2019 (COVID-19) was first detected in China in December, 2019, and declared as a pandemic by the World Health Organization (WHO) on March 11, 2020. The current management of COVID-19 is based generally on suppor …
INTRODUCTION: Coronavirus disease 2019 (COVID-19) was first detected in China in December, 2019, and declared as a pand …
Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection.
Safiabadi Tali SH, LeBlanc JJ, Sadiq Z, Oyewunmi OD, Camargo C, Nikpour B, Armanfard N, Sagan SM, Jahanshahi-Anbuhi S. Safiabadi Tali SH, et al. Clin Microbiol Rev. 2021 May 12;34(3):e00228-20. doi: 10.1128/CMR.00228-20. Print 2021 Jun 16. Clin Microbiol Rev. 2021. PMID: 33980687 Free PMC article. Review.
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory disease coronavirus 2 (SARS-CoV-2), has led to millions of confirmed cases and deaths worldwide. ...Diagnostic imaging techniques and bioma …
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory disease coronavirus 2 …
Detection technologies and recent developments in the diagnosis of COVID-19 infection.
Rai P, Kumar BK, Deekshit VK, Karunasagar I, Karunasagar I. Rai P, et al. Appl Microbiol Biotechnol. 2021 Jan;105(2):441-455. doi: 10.1007/s00253-020-11061-5. Epub 2021 Jan 4. Appl Microbiol Biotechnol. 2021. PMID: 33394144 Free PMC article. Review.
COVID-19 is a disease caused by SARS-CoV-2 capable of causing mild to severe infections in humans. ...However, proper diagnosis using rapid technologies plays a crucial role. With increasing incidence of COVID-19 cases, the accurat …
COVID-19 is a disease caused by SARS-CoV-2 capable of causing mild to severe infections in humans. ...How …
SARS-CoV-2 reinfection.
Romera I, Núñez K, Calizaya M, Baeza I, Molina R, Morillas J. Romera I, et al. Med Intensiva (Engl Ed). 2021 Aug-Sep;45(6):375-376. doi: 10.1016/j.medine.2021.04.009. Epub 2021 May 2. Med Intensiva (Engl Ed). 2021. PMID: 34294235 Free PMC article. No abstract available.
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.
Dunkle LM, Kotloff KL, Gay CL, Áñez G, Adelglass JM, Barrat Hernández AQ, Harper WL, Duncanson DM, McArthur MA, Florescu DF, McClelland RS, Garcia-Fragoso V, Riesenberg RA, Musante DB, Fried DL, Safirstein BE, McKenzie M, Jeanfreau RJ, Kingsley JK, Henderson JA, Lane DC, Ruíz-Palacios GM, Corey L, Neuzil KM, Coombs RW, Greninger AL, Hutter J, Ake JA, Smith K, Woo W, Cho I, Glenn GM, Dubovsky F; 2019nCoV-301 Study Group. Dunkle LM, et al. N Engl J Med. 2022 Feb 10;386(6):531-543. doi: 10.1056/NEJMoa2116185. Epub 2021 Dec 15. N Engl J Med. 2022. PMID: 34910859 Free PMC article. Clinical Trial.
BACKGROUND: NVX-CoV2373 is an adjuvanted, recombinant spike protein nanoparticle vaccine that was shown to have clinical efficacy for the prevention of coronavirus disease 2019 (Covid-19) in phase 2b-3 trials in the United Kingdom and South Africa, but its ef …
BACKGROUND: NVX-CoV2373 is an adjuvanted, recombinant spike protein nanoparticle vaccine that was shown to have clinical efficacy for the pr …
Advances in Technology to Address COVID-19.
Chow EK, Wong PK, Ding X. Chow EK, et al. SLAS Technol. 2020 Dec;25(6):511-512. doi: 10.1177/2472630320969634. SLAS Technol. 2020. PMID: 33215941 Free PMC article. No abstract available.
500,999 results
You have reached the last available page of results. Please see the User Guide for more information.